Adrenal gland disorder
MONDO:0005495A disease involving the adrenal gland.
Also known as: adrenal gland disease, adrenal gland disease or disorder, adrenal gland diseases, adrenal gland disorder, adrenal gland disorders, disease of adrenal gland, disease or disorder of adrenal gland, disorder of adrenal gland
354 clinical trials for this condition and its sub-types, 9 tagged with Adrenal gland disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Adrenal gland disorder
-
Adrenal cortex disorder 0 trials · 185 incl. sub-types
3 sub-types
- Adrenocortical insufficiency 33 trials · 76 incl. sub-types Sub-types →
- Adrenal cortex neoplasm 11 trials · 63 incl. sub-types Sub-types →
- Adrenal gland hyperfunction 1 trial · 60 incl. sub-types Sub-types →
-
Adrenal gland neoplasm 13 trials · 151 incl. sub-types
8 sub-types
- Adrenal cortex neoplasm 11 trials · 63 incl. sub-types Sub-types →
- Adrenal gland cancer 16 trials · 62 incl. sub-types Sub-types →
- Multiple endocrine neoplasia type 1 34 trials
- Cushing disease due to pituitary adenoma 23 trials
- Benign neoplasm of adrenal gland 0 trials · 19 incl. sub-types Sub-types →
- Pheochromocytoma-paraganglioma 18 trials
- Adrenal medulla neoplasm 0 trials · 16 incl. sub-types Sub-types →
- Pituitary dermoid and epidermoid cysts 0 trials
-
Adrenogenital syndrome 0 trials · 41 incl. sub-types
4 sub-types
- Congenital adrenal hyperplasia 36 trials · 38 incl. sub-types Sub-types →
- Glucocorticoid resistance 3 trials
- Acquired adrenogenital syndrome 0 trials
- Cortisone reductase deficiency 0 trials Sub-types →
-
Pituitary dwarfism 40 trials
2 sub-types
- Psychosocial short stature 0 trials
- Short stature due to partial GHR deficiency 0 trials
-
Endogenous Cushing syndrome 3 trials · 38 incl. sub-types
2 sub-types
- ACTH-dependent Cushing syndrome 23 trials · 26 incl. sub-types Sub-types →
- ACTH-independent Cushing syndrome 9 trials · 11 incl. sub-types Sub-types →
-
Adrenoleukodystrophy 19 trials · 20 incl. sub-types
3 sub-types
- Adrenomyeloneuropathy 7 trials
- X-linked cerebral adrenoleukodystrophy 4 trials
- Isolated adrenal insufficiency 0 trials
-
Ectopic ACTH secretion syndrome 15 trials
-
5 sub-types
- Pigmented nodular adrenocortical disease, primary, 1 1 trial
- Isolated primary pigmented nodular adrenocortical disease 0 trials
- Pigmented nodular adrenocortical disease, primary, 2 0 trials
- Pigmented nodular adrenocortical disease, primary, 3 0 trials
- Pigmented nodular adrenocortical disease, primary, 4 0 trials
-
Hypoaldosteronism disease 1 trial
1 sub-type
- Familial hypoaldosteronism 0 trials Sub-types →
-
Adrenal medullary hyperplasia 0 trials
-
Adrenomyodystrophy 0 trials
-
Medulloadrenal hyperfunction 0 trials
Most studied deeper sub-types
-
New hope for kids with rare hormone disorder: drug may cut steroid doses
Disease control Stopped earlyThis study tested an experimental drug called tildacerfont in 67 children aged 2 to 17 with congenital adrenal hyperplasia (CAH), a genetic condition that disrupts hormone production. The goal was to see if adding this once-daily pill to standard steroid treatment could improve d…
Phase 2 • Sponsor: Spruce Biosciences • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
PCOS drug trial halted early: did tildacerfont lower hormones?
Disease control Stopped earlyThis study tested a drug called tildacerfont in 27 women with polycystic ovary syndrome (PCOS) who had high levels of adrenal androgens (hormones). The goal was to see if the drug could safely lower these hormones. The trial was stopped early, so results are limited.
Phase 2 • Sponsor: Spruce Biosciences • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New drug aims to cut steroid use in rare hormone disorder
Disease control Stopped earlyThis study tested a daily tablet called Tildacerfont in 100 adults with classic congenital adrenal hyperplasia, a condition where the body can't make certain hormones properly. The goal was to see if the drug could safely reduce the high doses of steroids patients need to take. T…
Phase 2 • Sponsor: Spruce Biosciences • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC